# Research Peptide FAQ: Quality, Testing, Storage, and Platform Data
> Research use only. This page discusses laboratory handling, analytical verification, and regulatory context. It does not provide instructions for human or animal administration. Research compounds are not medicines unless a regulator has approved a specific product for a specific indication.
Researchers comparing peptide materials need answers that separate identity, purity, handling, and legal status. A chromatogram can support one part of that assessment, but no single document proves that a vial contains the stated sequence, amount, counterion, and microbiological quality.
What does “research use only” mean?
Research use only (RUO) identifies material intended for controlled laboratory work rather than diagnosis, treatment, or personal use. The label does not certify purity, sterility, identity, or regulatory approval. Each claim still needs evidence from the batch and from methods suitable for the intended experiment.
What should a useful certificate of analysis contain?
A useful certificate identifies the batch, test date, method, acceptance criterion, result, and responsible laboratory. At minimum, peptide identity and purity are different questions:
- •Identity: mass spectrometry can test whether the observed molecular mass fits the expected compound.
- •Purity: a validated chromatographic method can estimate the relative abundance of the principal peak and resolved impurities.
- •Quantity: net peptide content requires a quantitative method; vial fill weight and chromatographic area percentage do not establish it.
- •Microbiological quality: bioburden, endotoxin, or sterility testing is separate from chemical identity.
Mass-spectrometry multi-attribute methods can measure several product attributes, but method performance and sample preparation still control what the assay can detect (PMID 36018776). The COA interpretation guide explains how to read these fields together.
Is a high HPLC percentage enough?
No. HPLC purity is method-dependent and does not by itself prove sequence identity, absolute quantity, sterility, or freedom from every contaminant. A credible assessment pairs chromatography with an orthogonal identity method and records the actual method conditions.
Market surveillance illustrates the gap between a product label and measured material. A 2024 evaluation of semaglutide products bought from online sellers assessed seller practices, package contents, purity, and microbiological quality rather than accepting listing claims at face value (PMID 39509151).
How much supplier coverage does Peptides.SO show?
The platform snapshot queried on October 1, 2026 contained 9,864 listings from 111 active suppliers. Examples include 181 BPC-157 listings across 93 suppliers, 124 Selank listings across 86 suppliers, and 123 Semax listings across 85 suppliers. These counts describe marketplace coverage, not laboratory validation. At the same snapshot, none of 166 active supplier rows had a nonzero structured testing score or a stored CoA URL. Researchers should therefore inspect the batch documentation behind an individual listing rather than treating directory presence as proof of testing.
Use Compare Peptides to inspect listings, then check the relevant compound page for aliases and product context.
How should peptide materials be stored?
Follow the manufacturer or validated laboratory method for that exact sequence, salt, formulation, and container. “Peptides” are not one stability class. Temperature, water activity, pH, oxygen, light, interfaces, agitation, and sequence-specific reactions can all change stability. Reviews of protein and peptide instability describe denaturation, aggregation, oxidation, deamidation, and surface effects as distinct failure paths (PMID 36432723).
Record receipt condition, lot number, storage location, freeze-thaw history, and preparation date. See peptide storage best practices and degradation pathways.
Can a cloudy or coloured solution be used?
Unexpected cloudiness, particles, precipitate, colour change, damaged packaging, or a broken temperature record are reasons to quarantine the material and investigate. Visual clarity does not prove chemical or microbiological quality, and filtering an unexplained particulate can remove evidence without resolving the cause.
Can researchers substitute one peptide salt for another?
Not without accounting for the difference. Acetate, trifluoroacetate, hydrochloride, and other counterions can change molecular mass calculations, solubility, pH, and net peptide content. The material record should state the salt form and whether the reported quantity is gross vial mass or net peptide.
Why can two suppliers list very different prices?
Package size, concentration, formulation, test scope, geography, and data freshness can all change a listing price. The current platform medians per listed unit were $42 for BPC-157, $33.94 for Semax, $30.50 for Selank, $45 for semaglutide, and $31.67 for tirzepatide. Those values are marketplace observations, not quality rankings. Compare the exact variant and unit before drawing conclusions.
What records should a laboratory keep?
A defensible record links the supplier, purchase date, batch, received condition, CoA, raw analytical files, preparation calculation, operator, storage history, and experiment identifier. Preserve original documents rather than screenshots alone. If a result depends on purity or identity, include orthogonal testing in the study plan.
Where should a new researcher start?
Start with the research safety guide, the solubility guide, and the peptide calculator. The calculator supports concentration arithmetic; it does not choose a dose or establish suitability for administration.
References
1. Mouchahoir T, et al. Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study. 2022. PMID 36018776
2. Mackey K, et al. Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation. 2024. PMID 39509151
3. Emami F, et al. Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. 2022. PMID 36432723
> Research use only. This page discusses laboratory handling, analytical verification, and regulatory context. It does not provide instructions for human or animal administration. Research compounds are not medicines unless a regulator has approved a specific product for a specific indication.